OpenAI has officially launched the Rosalind Biodefense Program, a new initiative aimed at using artificial intelligence to strengthen biosecurity and pandemic preparedness. According to an announcement first shared exclusively with Axios, the program will grant trusted developers working on biodefense tools access to the GPT-Rosalind model—an AI system specifically designed for life science research. The goal is to accelerate key public health efforts, including epidemic modeling, early detection, screening, preparedness, and non-pharmaceutical interventions.
OpenAI says it will sponsor access for selected organizations and provide launch support, covering the full lifecycle of biological threats—from prevention and early detection to building social resilience and developing medical countermeasures. The initiative highlights AI’s transformative potential in biosecurity, while also raising important questions about dual-use risks, where the same technology could be misused to develop biological weapons.

